We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pulmonary Embolism Blood Tests Reduce Radiation Exposure

By HospiMedica International staff writers
Posted on 24 Dec 2019
A new study suggests that D-dimer blood tests can help rule out pulmonary embolism (PE), reducing the need for a diagnostic computerized tomography (CT) scan.

Researchers at McMaster University (Hamilton, ON, Canada), the University of Alberta (Edmonton, Canada), McGill University (Montreal, Canada), and other institutions conducted a prospective study involving 2,017 adult (average age 52 years, 66% female), of whom 7.4% had PE on initial diagnostic testing. More...
PE was considered to be ruled out without further testing in outpatients with a low clinical pretest probability (C-PTP) and a D-dimer level of less than 1000 ng per milliliter, or with a moderate C-PTP and a D-dimer level of less than 500 ng per milliliter.

All other suspected patients underwent chest imaging (usually CT pulmonary angiography); if PE was not diagnosed, the patients did not receive anticoagulant therapy. All patients were followed for 3 months to detect venous thromboembolism (VTE). The results revealed that none of patients who were ruled out based on C-PTP and d-dimer levels had VTE at follow-up. Of 1,863 patients who did not receive a diagnosis of PE initially, and did not receive anticoagulant therapy, one patient had VTE. The study was published on November 27, 2019, in the New England Journal of Medicine (NEJM).

“When a physician is concerned that PE may be present, chest imaging with CT pulmonary angiography is usually done in half of these patients. We wanted to find a way to reduce the number of CT scans that need to be done,” concluded lead author Professor Clive Kearon, MB, PhD, of McMaster University. “Our diagnostic strategy resulted in the use of chest imaging in 34.3% of patients, whereas a strategy in which PE is considered to be ruled out with a low C-PTP and a d-dimer level of less than 500 ng per milliliter would result in the use of chest imaging in 51.9%. This way of using D-dimer testing and clinical assessment reduced the need for CT scanning by one-third.”

D-dimer is a fibrin degradation product. It is so named because it contains two D fragments of the fibrin protein joined by a cross-link. Since its introduction in the 1990s, it has become an important test for patients with suspected thrombotic disorders. While a negative result practically rules out thrombosis, a positive result can indicate thrombosis, but does not rule out other potential causes. Its main use, therefore, is to exclude thromboembolic disease where the probability is low.

Related Links:
McMaster University
University of Alberta
McGill University



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: 123RF

AI-Enhanced Handheld Ultrasound Improves Carotid Plaque Detection

Handheld ultrasound can miss small or faint carotid plaque, creating uncertainty in community screening. This gap makes it harder for frontline clinicians to decide who needs confirmatory imaging, closer... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.